Flagship Pioneering Launches Bioplatform Innovation Hub in Singapore, Appoints André Andonian as Asia Pacific Chair

13 November 2023 | Monday | News

Flagship Pioneering, the trailblazing bioplatform innovation company, has expanded its global footprint into the dynamic Asia-Pacific region, establishing a regional hub in Singapore. André Andonian, a seasoned strategic advisor with over three decades of global experience, joins Flagship as Chair of Asia Pacific and Senior Advisor. This move follows the company's successful expansion into the UK earlier this year, marking a strategic milestone in Flagship's mission to foster breakthrough innovations for a healthier and more sustainable future.
André Andonian

André Andonian

Flagship Pioneering creates and builds platform companies designed to generate multiple products that secure a healthier and more sustainable future. For more than 20 years, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion (USD) in aggregate value. The current Flagship ecosystem comprises 43 impactful companies spanning human therapeutics, agriculture, and nutrition. 


The global expansion of Flagship's presence into the Asia Pacific region follows the opening of the company's office in London earlier this year. Later this month, Flagship will co-host an event in partnership with the UK Government's Office for Life Sciences, bringing together top leaders from industry, government, and academia, with a focus on breakthrough innovation.

"For more than two decades Flagship has systematically created breakthrough companies that push scientific boundaries and build enduring value, while ensuring a healthier and more sustainable future," said Noubar Afeyan, Ph.D., Founder and CEO of Flagship Pioneering. "Flagship's expansion into APAC through our new hub in Singapore, will allow us to accelerate the growth and scaling of our companies and enable us to broaden their impact on human health and the health of our planet through strategic partnerships across industry, academia, and healthcare systems in the region."

"Singapore has a thriving biomedical ecosystem built over more than two decades. Here, global and local life sciences and biotech companies can accelerate game-changing innovation and scale transformative solutions to meet the rising demand for healthcare in Asia. The presence of Flagship Pioneering in Singapore will boost new collaborations in our growing region, driving healthcare and sustainability impact," said Jacqueline Poh, Managing Director, Singapore Economic Development Board (EDB) and Director, EDBI.

Afeyan continued, "I am delighted to welcome André to Flagship. André's deep and longstanding experience working throughout Asia with companies, investors, governments, and other stakeholders will be instrumental in identifying and building meaningful relationships between this vibrant regional ecosystem, Flagship, and our first-in-category platform companies."

"It is an honor to join Flagship Pioneering and its leadership team to help introduce the company and its unique approach to innovation, impact, and value creation to the APAC region," said André Andonian, Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering. "I look forward to leveraging the many opportunities that exist across Asia to build relationships and partnerships that help Flagship and its bioplatform companies as they grow and scale in pursuit of maximum impact for patients and the planet."

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in